WMSA
HRTX icon

Weiss Multi-Strategy Advisers’s Heron Therapeutics HRTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-90,000
Closed -$153K – 225
2023
Q4 		$153K Sell
90,000
-38,559
-30% -$42.5K ﹤0.01% 513
2023
Q3 		$132K Sell
128,559
-15,133
-11% -$21.5K ﹤0.01% 521
2023
Q2 		$167K Sell
143,692
-14,834
-9% -$26.5K ﹤0.01% 609
2023
Q1 		$239K Sell
158,526
-2,779
-2% -$6.96K 0.01% 583
2022
Q4 		$403K Sell
161,305
-3,695
-2% -$11.9K 0.01% 526
2022
Q3 		$696K Buy
165,000
+129,304
+362% +$506K 0.02% 529
2022
Q2 		$100K Sell
35,696
-7,132
-17% -$28.6K ﹤0.01% 635
2022
Q1 		$245K Buy
42,828
+328
+0.8% +$2.4K 0.01% 617
2021
Q4 		$388K Buy
42,500
+21,757
+105% +$222K 0.01% 566
2021
Q3 		$222K Buy
20,743
+454
+2% +$5.53K ﹤0.01% 621
2021
Q2 		$315K Buy
20,289
+984
+5% +$15.7K 0.01% 595
2021
Q1 		$313K Sell
19,305
-790
-4% -$14.1K 0.01% 597
2020
Q4 		$425K Sell
20,095
-5,121
-20% -$89K 0.01% 586
2020
Q3 		$374K Sell
25,216
-4,284
-15% -$66.8K 0.01% 503
2020
Q2 		$434K Sell
29,500
-1,390
-4% -$22.8K 0.01% 476
2020
Q1 		$363K Sell
30,890
-1,110
-3% -$20.9K 0.01% 363
2019
Q4 		$752K Buy
32,000
+22,000
+220% +$487K 0.01% 511
2019
Q3 		$185K Hold
10,000
– – ﹤0.01% 549
2019
Q2 		$186K Buy
+10,000
New +$200K ﹤0.01% 470

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Weiss Multi-Strategy Advisers's HRTX Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Heron Therapeutics (HRTX) in Q1 2024, closing a stake of 90,000 shares — an estimated $153K sold.

Weiss Multi-Strategy Advisers first reported a position in HRTX in Q2 2019 and held it in 19 quarters. The position peaked at $752K in Q4 2019. 161 funds tracked by Wall St. Rank hold HRTX as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Heron Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 90,000 Heron Therapeutics shares in Q1 2024, an estimated $153K.
  • Weiss Multi-Strategy Advisers first reported a position in Heron Therapeutics in Q2 2019 and held it in 19 quarters.
  • Weiss Multi-Strategy Advisers's Heron Therapeutics position peaked at $752K in Q4 2019.
  • 161 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.